Skip to main content
Equibles
ALZN logo

ALZN · Alzamend Neuro, Inc.

Track ALZN — free

Use ALZN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.70 +0.06 (+3.86%)
Rebalance outlook locked
Going-concern doubt — flagged Jul 22, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our independent registered public accounting firm has issued a report on our financial statements for the year ended April 30, 2026, that contains an emphasis of a matter paragraph expressing substantial doubt about our ability to continue as a going concern due to insufficient capital for us to fund our operations.”
View the 10-K filed Jul 22, 2026
Market Cap
$7.67M
Shares
4.79M

Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.

No Congressional Trades

No congressional trading data is available for this stock yet.

Key facts CIK 1677077 CUSIP 02262M605 13F (30d) 11 filings 10 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)